| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 27.68% | 0.00% | -2.86% | 0 | -56.96% | 2025-10-13 |
| 2 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 32.01% | 0.00% | -2.86% | 0 | -56.96% | 2025-10-10 |
| 3 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 35.84% | 0.00% | -2.86% | 0 | -56.96% | 2025-10-09 |
| 4 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 57.26% | 42.67% | -2.86% | 0 | -56.96% | 2025-06-16 |
| 5 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 58.82% | 39.79% | -2.86% | 0 | -56.96% | 2025-06-17 |
| 6 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 67.04% | 40.50% | -2.86% | 0 | -56.96% | 2025-06-26 |
| 7 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 10.95% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-04 |
| 8 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 37.61% | 0.00% | -2.86% | 0 | -56.96% | 2025-09-24 |
| 9 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 38.59% | 0.00% | -2.86% | 0 | -56.96% | 2025-09-25 |
| 10 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 10.95% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-03 |
| 11 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 14.04% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-17 |
| 12 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 28.71% | 0.00% | -2.86% | 0 | -56.96% | 2025-09-29 |
| 13 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 28.71% | 0.00% | -2.86% | 0 | -56.96% | 2025-09-30 |
| 14 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 63.42% | 31.23% | -2.86% | 0 | -56.96% | 2025-06-27 |
| 15 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 64.63% | 37.61% | -2.86% | 0 | -56.96% | 2025-06-24 |
| 16 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 63.07% | 34.98% | -2.86% | 0 | -56.96% | 2025-06-19 |
| 17 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 63.19% | 31.12% | -2.86% | 0 | -56.96% | 2025-06-20 |
| 18 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 64.53% | 37.43% | -2.86% | 0 | -56.96% | 2025-06-23 |
| 19 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 10.95% | 0.00% | -2.86% | 0 | -56.96% | 2025-10-30 |
| 20 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 10.95% | 0.00% | -2.86% | 0 | -56.96% | 2025-10-31 |